Studies have shown that silymarin can protect against NASH induced by an MCD diet by interfering with the inflammatory cytokine TNF-α, inhibiting the activation of HSCs, and reducing the expression of α1-procollagen in HSCs [47]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatohepatitis.